🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 14/12/2018 | 0,5248 USD |
| 14/09/2018 | 0,4580 USD |
| 14/06/2018 | 0,4580 USD |
| 14/03/2018 | 0,4580 USD |
| 14/12/2017 | 0,4580 USD |
| 14/09/2017 | 0,4485 USD |
| 13/06/2017 | 0,4485 USD |
| 13/03/2017 | 0,4485 USD |
| 13/12/2016 | 0,4485 USD |
| 13/09/2016 | 0,4389 USD |
| 13/06/2016 | 0,4389 USD |
| 11/03/2016 | 0,4389 USD |
| 11/12/2015 | 0,4389 USD |
| 11/09/2015 | 0,4294 USD |
| 11/06/2015 | 0,4294 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 27/07/2005 | 29,23 | 29,96 | 29,22 | 29,79 | +1,73% | 2,55% | 6.302.672 |
| 26/07/2005 | 29,37 | 29,69 | 29,21 | 29,28 | -0,16% | 1,66% | 6.479.679 |
| 25/07/2005 | 29,63 | 29,67 | 29,22 | 29,33 | -1,28% | 1,51% | 7.368.174 |
| 22/07/2005 | 29,94 | 29,94 | 29,47 | 29,71 | -0,76% | 1,59% | 6.319.440 |
| 21/07/2005 | 30,01 | 30,23 | 29,41 | 29,94 | -1,48% | 2,73% | 9.634.159 |
| 20/07/2005 | 30,37 | 30,66 | 30,01 | 30,39 | -0,31% | 2,14% | 6.772.490 |
| 19/07/2005 | 30,46 | 30,63 | 30,09 | 30,49 | +0,22% | 1,79% | 6.137.193 |
| 18/07/2005 | 30,45 | 30,86 | 30,31 | 30,42 | -0,09% | 1,79% | 6.527.678 |
| 15/07/2005 | 30,46 | 30,82 | 30,31 | 30,45 | +0,00% | 1,66% | 7.159.726 |
| 14/07/2005 | 30,30 | 30,55 | 30,21 | 30,45 | +0,92% | 1,13% | 7.103.449 |
| 13/07/2005 | 30,30 | 30,30 | 29,97 | 30,17 | +0,06% | 1,07% | 6.435.139 |
| 12/07/2005 | 29,65 | 30,25 | 29,60 | 30,15 | +1,15% | 2,19% | 11.002.428 |
| 11/07/2005 | 29,29 | 29,84 | 29,22 | 29,81 | +0,77% | 2,12% | 8.450.967 |
| 08/07/2005 | 28,67 | 29,62 | 28,67 | 29,58 | +3,40% | 3,29% | 11.888.617 |
| 07/07/2005 | 28,91 | 29,27 | 28,53 | 28,61 | -1,90% | 2,54% | 12.928.757 |
| 06/07/2005 | 29,82 | 29,84 | 29,10 | 29,16 | -1,74% | 2,46% | 6.296.174 |
| 05/07/2005 | 29,69 | 29,77 | 29,26 | 29,68 | +0,13% | 1,74% | 6.106.696 |
| 01/07/2005 | 29,39 | 29,91 | 29,39 | 29,64 | +0,84% | 1,79% | 8.414.078 |
| 30/06/2005 | 29,96 | 29,96 | 29,20 | 29,39 | -0,10% | 2,55% | 8.889.555 |
| 29/06/2005 | 29,58 | 29,62 | 29,29 | 29,42 | -0,45% | 1,10% | 7.061.319 |
| 28/06/2005 | 29,37 | 29,69 | 29,20 | 29,55 | +1,54% | 1,69% | 7.830.551 |
| 27/06/2005 | 29,01 | 29,47 | 29,01 | 29,10 | -0,16% | 1,58% | 7.580.918 |
| 24/06/2005 | 29,70 | 29,79 | 29,06 | 29,15 | -2,24% | 2,47% | 10.520.872 |
| 23/06/2005 | 30,45 | 30,45 | 29,79 | 29,82 | -2,28% | 2,16% | 10.144.745 |
| 22/06/2005 | 30,76 | 30,76 | 30,45 | 30,52 | -0,03% | 1,02% | 6.827.406 |
| 21/06/2005 | 30,73 | 30,80 | 30,42 | 30,52 | -0,37% | 1,24% | 5.898.144 |
| 20/06/2005 | 30,53 | 30,81 | 30,46 | 30,64 | -0,34% | 1,16% | 6.209.714 |
| 17/06/2005 | 31,01 | 31,01 | 30,41 | 30,74 | +0,69% | 1,94% | 11.570.758 |
| 16/06/2005 | 30,53 | 30,70 | 30,43 | 30,53 | +0,31% | 0,88% | 6.149.454 |
| 15/06/2005 | 30,29 | 30,53 | 30,09 | 30,44 | +0,38% | 1,48% | 7.178.066 |